Top Losers

Camtek (NASDAQ: CAMT) shares declined 6.18% to $4.71 in pre-market trading after jumping 56.87% on Monday. SeaDrill (NYSE: SDRL) dropped 4.17% to $37.95 in pre-market trading. Seadrill launched $1 billion 2019 convertible bond concurrently with a voluntary incentive payment offer to convert the...

USEC (NYSE: USU) dipped 17.57% to $6.05. USEC shares have jumped 114.96% over the past 52 weeks, while the S&P 500 index has gained 21.67% in the same period. China BAK Battery (NASDAQ: CBAK) shares declined 14.81% to $3.45 after surging 13.76% on Thursday. GT Advanced Technologies (NASDAQ:...

GT Advanced Technologies (NASDAQ: GTAT) dropped 8.26% to $17.88 in pre-market trading. Canaccord Genuity downgraded GT Advanced from Buy to Hold. Central European Media Enterprises (NASDAQ: CETV) shares declined 3.18% to $2.74 in pre-market trading after falling 0.35% on Thursday. Arena...

Regado Biosciences (NASDAQ: RGDO) dropped 57.10% to $2.90 following the announcement of halt of patient enrollment in REGULATE-PCI trial. Wedbush downgraded Regado Biosciences from Outperform to Underperform. NQ Mobile (NYSE: NQ) shares slipped 29.59% to $4.76 after the company announced certain...

Regado Biosciences (NASDAQ: RGDO) dropped 42.31% to $3.90 in pre-market trading following the announcement of halt of patient enrollment in REGULATE-PCI trial. Wedbush downgraded Regado Biosciences from Outperform to Underperform. BIND Therapeutics (NASDAQ: BIND) shares declined 12.66% to $11.25 in...

CalAmp (NASDAQ: CAMP) dropped 12.96% to $19.20 after the company issued a weak forecast for the second quarter. It expected Q2 earnings of $0.17 to $0.21 per share on revenue of $57 million to $61 million. Analysts estimated earnings of $0.22 per share on revenue of $62.2 million. Molycorp (NYSE...

Molycorp (NYSE: MCP) dropped 17.51% to $2.12 in pre-market trading. The decline in the stock may be attributed to Seeking Alpha post: 'Molycorp Is Worth $1.60 Per Share.' CalAmp (NASDAQ: CAMP) shares declined 13.19% to $19.15 in pre-market trading after the company issued a weak forecast for the...

Synageva BioPharma (NASDAQ: GEVA) shares tumbled 8.22% to $96.19 after the company reported that Phase 3 study met primary endpoint and six secondary endpoints across multiple disease-related abnormalities. Citigroup initiated coverage on Synageva BioPharma with a Neutral rating. Acuity Brands (...

Urban Outfitters (NASDAQ: URBN) dropped 3.96% to $32.52 in pre-market trading as Wedbush downgraded the stock from Outperform to Neutral. MannKind (NASDAQ: MNKD) shares declined 2.01% to $10.74 in pre-market trading after surging 9.60% on Monday. Symantec (NASDAQ: SYMC) fell 1.75% to $22.50 in pre...

American Apparel (NYSE: APP) shares declined 18.41% to $0.79 after the company announced Dov Charney's special meeting request is invalid. On Saturday, American Apparel adopted a one-year stockholder rights plan. Tower Group International (NASDAQ: TWGP) shares fell 18.27% to $1.66. Tower Group...

American Apparel (NYSE: APP) dropped 12% to $0.85 in pre-market trading after the company announced Dov Charney's special meeting request is invalid. On Saturday, American Apparel adopted a one-year stockholder rights plan. Central European Media Enterprises (NASDAQ: CETV) dipped 1.42% to $2.78 in...

Retrophin (NASDAQ: RTRX) shares declined 6.82% to $11.00 in pre-market trading following the announcement of temporary halt of RE-024 patient dosing. Isis Pharmaceuticals (NASDAQ: ISIS) dipped 3.82% to $34.99 in pre-market trading after gaining 0.78% on Thursday. The decline in the stock may be...

Kingtone Wirelessinfo Solution Holding (NASDAQ: KONE) fell 14.05% to $5.50 after the company reported financial results for the six months ended March 31, 2014. The company posted a net loss of around $0.7 million in the period. Elizabeth Arden (NASDAQ: RDEN) shares declined 13% to $23.49 after LG...

Bed Bath & Beyond (NASDAQ: BBBY) shares declined 7.81% to $56.34 in pre-market trading after the company reported weaker-than-expected fiscal first-quarter results and issued a downbeat outlook for the second quarter. Philip Morris International (NYSE: PM) dipped 2.18% to $87.42 in pre-market...

Actinium Pharmaceuticals (NYSE: ATNM) tumbled 16.57% to $7.30 after the company announced a secondary offering of its shares. NeuroMetrix (NASDAQ: NURO) shares slipped 9.82% to $2.02 after the company announced a $8 million preferred stock placement. Heron Therapeutics (NASDAQ: HRTX) fell 9.55% to...